RPID Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. The setup looks extended (RSI elevated, momentum easing) with no proprietary buy signals and weak short-term pattern odds (next week/month biased down). Wait for a pullback closer to support (~4.27 or below) or a fresh catalyst before considering entry.
Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200, suggesting an established uptrend. Momentum: MACD histogram is positive (0.106) but “positively contracting,” implying bullish momentum is fading rather than accelerating. RSI: RSI_6 at ~73.7 is elevated (near overbought), increasing the odds of near-term consolidation/pullback rather than a clean continuation. Levels: Pivot 4.267 (key near-term support). Resistance R1 4.84 then R2 5.194. Current 4.61 sits above pivot but below R1—reward to resistance is limited versus downside to pivot/support. Tape/near-term: Pre-market -2.78% hints at immediate softness. Pattern-based forward view: Similar candlestick analogs suggest ~-5.08% over the next week and ~-2.84% over the next month, which does not favor chasing now.
Intellectia Proprietary Trading Signals
Gross margin improved YoY (2025/Q3 gross margin 8.88%, +8.56% YoY).
Revenue grew modestly YoY in 2025/Q3 (+3.08%).
Moving averages remain aligned bullish (trend support).
No news/catalyst in the last week to drive a fresh leg higher.
RSI is elevated and MACD momentum is contracting, increasing pullback risk.
Analog/pattern projection is negative for next week/month.
Company remains loss-making (2025/Q3 net income -11.505M).
Latest quarter: 2025/Q3. Revenue was 7.838M (+3.08% YoY), indicating mild top-line growth. Losses persist (net income -11.505M, improved slightly YoY), and EPS was -0.26. Gross margin improved to 8.88% (+8.56% YoY), but profitability is still far from sustainable, so the fundamental momentum is improving only marginally.
No analyst rating or price target change data provided, so a Wall Street pros/cons read cannot be confirmed from the dataset. Based on the available information only: pros are improving gross margin and modest revenue growth; cons are ongoing sizable losses and lack of near-term catalysts.
